StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Madrigal Pharma (MDGL) Halted, News Pending
March 14, 2024 3:30 PM
Madrigal Pharma ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Trading Halts
Next Articles
Madrigal Pharmaceuticals (MDGL) PT Raised to $425 at H.C. Wainwright, 'Rezdiffra Achieves Landmark Approval'
March 15, 2024 6:11 AM
Madrigal Pharmaceuticals (MDGL) PT Raised to $389 at Citi
March 15, 2024 3:49 AM
Madrigal Pharma (MDGL) Confirms FDA Approval of Rezdiffra for Treatment of Patients with Noncirrhotic NASH with Moderate to Advanced Liver Fibrosis
March 14, 2024 4:16 PM
